Cargando…
Reprogramming Cancer Cells to Antigen-presenting Cells
Cancer cells evade the immune system by downregulating antigen presentation. Although immune checkpoint inhibitors (ICI) and adoptive T-cell therapies revolutionized cancer treatment, their efficacy relies on the intrinsic immunogenicity of tumor cells and antigen presentation by dendritic cells. He...
Autores principales: | Ferreira, Alexandra G., Zimmermannova, Olga, Kurochkin, Ilia, Ascic, Ervin, Åkerström, Fritiof, Pereira, Carlos-Filipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bio-Protocol
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665638/ https://www.ncbi.nlm.nih.gov/pubmed/38023788 http://dx.doi.org/10.21769/BioProtoc.4881 |
Ejemplares similares
-
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
por: Zimmermannova, Olga, et al.
Publicado: (2021) -
Understanding and Modulating Immunity With Cell Reprogramming
por: Pires, Cristiana F., et al.
Publicado: (2019) -
Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming
por: Schmitt, Christopher E., et al.
Publicado: (2017) -
Medullary Thymic Epithelial Cell Antigen-presentation Assays
por: Borelli, Alexia, et al.
Publicado: (2023) -
Novel live cell fluorescent probe for human-induced pluripotent stem cells highlights early reprogramming population
por: Sriram, Sandhya, et al.
Publicado: (2021)